PLACERVILLE, California, May 2, 2016 (LifeSiteNews) – StemExpress – the corporate partner that paid Planned Parenthood for aborted babies' body parts and tissue – grew by a whopping 1,316 percent in three years, and its revenue more than doubled in a single year, according to business authorities.
The tissue and blood procurement company went into business in 2010, generating barely $100,000, according to reports.
By 2013, the company had $2.2 million in revenues.
A year later, StemExpress reported $4.5 million in revenue – more than a 100 percent increase in funds in one year.
StemExpress grew by a whopping 1,316 percent during the previous three years, according to the website Inc.com.
The firm's business acumen garnered a spot as number 35 on Inc.com's list of fastest growing women-led companies last August – and number 363 on the “Inc. 5,000.”
Its description says the company “[s]upplies biomedical researchers with human blood, tissue products, bone marrow, primary cells, and the clinical specimens they need to perform their research.”
StemExpress noted the honor on its website.
That fall, the Center for Medical Progress released footage of StemExpress CEO Cate Dyer telling undercover investigators that her company shipped “a lot” of “intact” aborted babies' bodies to researchers nationwide. “Their lab techs freak out and have meltdowns” when they open the boxes, Dyer said, giggling and re-enacting their shocked expressions as they open containers containing complete fetal cadavers.
Documents released by Congress last month show that, in 2015, StemExpress was positioned to push into new territory, maximizing its relationship with abortion facilities to gather a larger number of unborn children's organs and tissue. According to the documents released by the House Select Panel on Infant Lives late last month, the number of abortion facilities that have agreed to furnish what the industry terms “products of conception” to StemExpress more than doubled between 2014 and 2015, as well, from less than 100 to 250 abortion facilities.
The company's explosive growth has ignited legal controversy. Its brochures promise a new revenue stream to abortion facilities that partner with the company, which is headquartered in Placerville, California. But federal law forbids exchanging human organs of any sort for “valuable consideration” – legally defined as any amount of money that would constitute a profit.
Two of the leading forces behind codifying this provision in the mid-1990s' National Institutes of Health (NIH) Revitalization Act were Rep. John Dingell of Michigan and Rep. Henry Waxman, both Democrats who favored abortion-on-demand, according to the House Select Panel Chairwoman Marsha Blackburn, R-TN.
CMP investigators revealed that Dyer is well-connected in the public sector, as well as the private sector.
Dyer boasted, “I have a signed picture from Hillary, because my sister works in Congress.” Dyer's sister, Charlotte Ivancic, resigned as health policy adviser to then-House Speaker John Boehner shortly before Boehner himself resigned from office.
“I, like, brought it into work the next day and propped it right on my desk,” she said.
